510(k) device
Tbi
Abbott Laboratories · Brain Trauma Assessment Test (QAT, Class II) · First FDA decision Sep 29, 2023, newest Sep 29, 2023Traumatic brain injury and concussion
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
380
Naming "Tbi"
MAUDE reports
32
Brand "Tbi", since 2015
PubMed studies
40,847
Mentioning "Tbi"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Tbi
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- TBI510(k)
K232669 · Decided Sep 29, 2023 · 28 days after receipt
Device type: Brain Trauma Assessment Test (QAT) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Tbi", any status and sponsor, newest update first.
State University of New York - Upstate Medical UniversityAcademic, hospital or other
NCT06112093 · 60 participants (planned) · Start Oct 23, 2023 · Primary completion Oct 23, 2028
Device: Repetitive Transcranial Magnetic Stimulation; Sham Repetitive Transcranial Magnetic Stimulation · For: Brain Concussion; Mild Traumatic Brain Injury; Headache and 1 more
Sites: Syracuse, New York
- Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain InjuryRecruiting
VA Office of Research and DevelopmentFederal agency
NCT05647044 · 55 participants (planned) · Start May 20, 2024 · Primary completion Mar 31, 2028
Device: intermittent theta burst stimulation; placebo intermittent theta burst stimulation · For: Mild Traumatic Brain Injury; Suicidal Ideation; Impulsivity
Sites: Hines, Illinois
Sima MofakhamAcademic, hospital or other
NCT07719595 · 10 participants (planned) · Start Jun 26, 2026 · Primary completion Dec 2029
Device: Dual-Site Transcutaneous Auricular Nerve Stimulation (taVNS + taTNS) · For: Traumatic Brain Injury; Severe Traumatic Brain Injury; Disorders of Consciousness Due to Severe Brain Injury and 1 more
Sites: Stony Brook, New York
377 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Tbi", and for the whole product code for context.
This brand
32 reports: 17 malfunction, 15 injury, 0 death
Whole product code QAT
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
- OME8C-TBI VER4 (D)Malfunction
3009561595-2024-00002 · Received Apr 22, 2024
Device type: Microscope, Surgical (EPT)
Device problem as coded: Material Split, Cut or Torn
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- OME8C-TBI VER4 (D)Malfunction
3009561595-2024-00001 · Received Mar 13, 2024
Device type: Microscope, Surgical (EPT)
Device problem as coded: Material Split, Cut or Torn
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- OME8C-TBI VER4 (D)Malfunction
3009561595-2023-00011 · Received Nov 7, 2023
Device type: Microscope, Surgical (EPT)
Device problem as coded: Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Tbi"[tiab]. The summary above synthesizes these.
- Traumatic brain injury in companion animals: Pathophysiology and treatment.
Wart M, Edwards TH, Rizzo JA, et al. · Top Companion Anim Med · 2024Review
- What Happens in TBI? A Wide Talk on Animal Models and Future Perspective.
Kundu S, Singh S · Curr Neuropharmacol · 2023Review
- Editorial: Total marrow irradiation.
Hui SK, Storme G, Wong J, et al. · Front Oncol · 2023Editorial
- Traumatic brain injury.
Huang JH · Neurol Res · 2013Editorial, Introductory Journal Article
- Head trauma.
Gean AD, Fischbein NJ · Neuroimaging Clin N Am · 2010Review
- Emotional Traumatic Brain Injury.
Shulman LM · Cogn Behav Neurol · 2020Personal Narrative
- Iron overload enhances TBI-induced cardiac dysfunction by promoting ferroptosis and cardiac inflammation.
Peng R, Liu X, Wang C, et al. · Biochem Biophys Res Commun · 2023Research Support, Non-U.S. Gov't
- Global Epidemiology of Pediatric Traumatic Brain Injury: Systematic Review and Meta-Analysis.
Baticulon RE, Sy JJ, Haizel-Cobbina J, et al. · Neurosurgery · 2026Systematic Review, Meta-Analysis
- The neuro-ophthalmology of head trauma.
Ventura RE, Balcer LJ, Galetta SL · Lancet Neurol · 2014Research Support, Non-U.S. Gov't, Review
- Continuous TBI Monitoring From Spontaneous Speech Using Parametrized Sinc Filters and a Cascading GRU.
Ditthapron A, Lammert AC, Agu EO · IEEE J Biomed Health Inform · 2022Research Support, U.S. Gov't, Non-P.H.S.
- Neuroprotection of NRF2 against Ferroptosis after Traumatic Brain Injury in Mice.
Cheng H, Wang P, Wang N, et al. · Antioxidants (Basel) · 2023
Other devices of this type
Also filed under product code QAT.
- Vidas Tbi (Gfap, UCH-L1)bioMerieux, Inc. · 510(k) 2024
- i-STAT TBI Cartridge with the i-STAT Alinity SystemAbbott Point of Care · 510(k) 2024
- Traumatic brain injury (TBI) testAbbott Laboratories · 510(k) 2023
- i-STAT TBI Plasma cartridge with the i-STAT Alinity SystemAbbott Laboratories · 510(k) 2021
- Banyan BTIBanyan Biomarkers, Inc. · De Novo 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.